These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3291697)

  • 41. Pulmonary vascular effects of vasoactive intestinal peptide in conscious newborn lambs.
    Kulik TJ; Johnson DE; Elde RP; Lock JE
    Am J Physiol; 1984 May; 246(5 Pt 2):H716-9. PubMed ID: 6720984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of vasoactive intestinal peptide and other neuropeptides in the regulation of the immune response in vitro and in vivo.
    Stanisz AM; Scicchitano R; Bienenstock J
    Ann N Y Acad Sci; 1988; 527():478-85. PubMed ID: 3291699
    [No Abstract]   [Full Text] [Related]  

  • 43. Intracoronary infusion of vasoactive peptides.
    Lancet; 1989 Nov; 2(8672):1165. PubMed ID: 2572894
    [No Abstract]   [Full Text] [Related]  

  • 44. Nonadrenergic neural vasodilator mechanisms.
    Bevan JA; Brayden JE
    Circ Res; 1987 Mar; 60(3):309-26. PubMed ID: 2438066
    [No Abstract]   [Full Text] [Related]  

  • 45. Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow.
    Feliciano L; Henning RJ
    Cardiovasc Res; 1998 Oct; 40(1):45-55. PubMed ID: 9876316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha adrenergic constriction of coronary arteries in conscious dogs.
    Vatner SF; Pagani M; Manders WT
    Trans Assoc Am Physicians; 1979; 92():229-38. PubMed ID: 232943
    [No Abstract]   [Full Text] [Related]  

  • 47. Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat.
    Nandiwada PA; Kadowitz PJ; Said SI; Mojarad M; Hyman AL
    J Appl Physiol (1985); 1985 May; 58(5):1723-8. PubMed ID: 3997734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasoactive intestinal peptide causes nitric oxide-dependent pulmonary vasodilation in isolated rat lung.
    Iwabuchi S; Ono S; Tanita T; Koike K; Fujimura S
    Respiration; 1997; 64(1):54-8. PubMed ID: 9044476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vasoactive intestinal polypeptide loses its ability to increase vaginal blood flow after menopause.
    Palle C; Bredkjaer HE; Fahrenkrug J; Ottesen B
    Am J Obstet Gynecol; 1991 Feb; 164(2):556-8. PubMed ID: 1992701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pituitary adenylate cyclase activating polypeptide: a neuropeptide with potent inotropic and coronary vasodilatory effects in neonatal pig hearts.
    Ross-Ascuitto NT; Ascuitto RJ; Ramage D; Kydon DW; Coy DH; Kadowitz PJ
    Pediatr Res; 1993 Sep; 34(3):323-8. PubMed ID: 7510869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Innervation of human epicardial coronary veins: immunohistochemistry and vasomotility.
    Saetrum Opgaard O; Gulbenkian S; Bergdahl A; Barroso CP; Andrade NC; Polak JM; Queiroz e Melo JQ; Edvinsson L
    Cardiovasc Res; 1995 Apr; 29(4):463-8. PubMed ID: 7540955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vasoactive intestinal polypeptide (VIP): effects in the eye and on regional blood flows.
    Nilsson SF; Bill A
    Acta Physiol Scand; 1984 Aug; 121(4):385-92. PubMed ID: 6148840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glutathione causes coronary vasodilation via a nitric oxide- and soluble guanylate cyclase-dependent mechanism.
    Cheung PY; Schulz R
    Am J Physiol; 1997 Sep; 273(3 Pt 2):H1231-8. PubMed ID: 9321811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspects of coronary vasomotor regulation.
    Hoffman JI; Piedimonte G; Maxwell AJ; Nadel JA; Iwanaga S; Husseini WK
    Adv Exp Med Biol; 1995; 381():135-46. PubMed ID: 8867830
    [No Abstract]   [Full Text] [Related]  

  • 55. Vasoactive intestinal peptide: a chronoimmunomodulator?
    Cugini P; Lucia P; Di Palma L; Pozzilli P; Re M; Canova R; Gasbarrone L; Cianetti A
    Biochem Med Metab Biol; 1991 Oct; 46(2):274-6. PubMed ID: 1782019
    [No Abstract]   [Full Text] [Related]  

  • 56. Hyperemin, a new vasoactive substance which regulates the metabolic responses of the coronaries.
    Szentivanyi M; Juhasz-Nagy A; Debreceni L
    Experientia; 1966 Mar; 22(3):171-3. PubMed ID: 5959931
    [No Abstract]   [Full Text] [Related]  

  • 57. Vasoactive intestinal peptide as a coronary vasodilator.
    Smitherman TC; Dehmer GJ; Said SI
    Ann N Y Acad Sci; 1988; 527():421-30. PubMed ID: 3291697
    [No Abstract]   [Full Text] [Related]  

  • 58. Action and localization of vasoactive intestinal peptide in the coronary circulation: evidence for nonadrenergic, noncholinergic coronary regulation.
    Brum JM; Bove AA; Sufan Q; Reilly W; Go VL
    J Am Coll Cardiol; 1986 Feb; 7(2):406-13. PubMed ID: 3944362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasoactive intestinal peptide in the heart.
    Forssmann WG; Triepel J; Daffner C; Heym C; Cuevas P; Noble MI; Yanaihara N
    Ann N Y Acad Sci; 1988; 527():405-20. PubMed ID: 3291696
    [No Abstract]   [Full Text] [Related]  

  • 60. Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart.
    Sawmiller DR; Ashtari M; Urueta H; Leschinsky M; Henning RJ
    Neuropeptides; 2006 Oct; 40(5):349-55. PubMed ID: 17030371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.